Standard BioTools Inc (NAS:LAB)
$ 1.81 -0.05 (-2.69%) Market Cap: 671.79 Mil Enterprise Value: 386.18 Mil PE Ratio: 0 PB Ratio: 1.31 GF Score: 62/100

Fluidigm Corp at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 07:00PM GMT
Release Date Price: $6.04 (-0.66%)
Dan Arias
Stifel Financial Corp. - Managing Director

Welcome back, again, everybody, to the 2020 Stifel Healthcare conference. We are continuing with the life sciences and diagnostics track day two.

Our next presenting company is Fluidigm. And we're happy to have CEO, Chris Linthwaite, with us. Chris, I'm going to turn over the floor to you and then you can go through your presentation. I'll circle back around when you're done.

Chris Linthwaite
Fluidigm Corporation - President and CEO

Sounds good. Thank you very much, Dan, for the invitation and for the kickoff, and thank you to the team for including us in the healthcare conference.

So, my name is Chris Linthwaite. I'm CEO of Fluidigm Corporation. This presentation will include some forward-looking statements. For full GAAP and non-GAAP reconciliation, you can refer to our website on the Investor Relations page.

So, Fluidigm's primary mission is -- and goal is to drive meaningful insights into health and disease with an ultimate goal to improve health and improve life itself.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot